Project
Inflammatory response time course, HUVEC (Wada et al., 2009)
Navigation
Downloads
Results for MAZ_ZNF281_GTF2F1
Z-value: 2.68
Motif logo
Transcription factors associated with MAZ_ZNF281_GTF2F1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MAZ
|
ENSG00000103495.9 | MYC associated zinc finger protein |
|
ZNF281
|
ENSG00000162702.7 | zinc finger protein 281 |
|
GTF2F1
|
ENSG00000125651.9 | general transcription factor IIF subunit 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| GTF2F1 | hg19_v2_chr19_-_6393465_6393479 | -0.66 | 3.1e-04 | Click! |
| ZNF281 | hg19_v2_chr1_-_200379180_200379191 | -0.65 | 5.0e-04 | Click! |
| MAZ | hg19_v2_chr16_+_29819446_29819471 | 0.60 | 1.4e-03 | Click! |
Activity profile of MAZ_ZNF281_GTF2F1 motif
Sorted Z-values of MAZ_ZNF281_GTF2F1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr17_-_58469591 | 18.14 |
ENST00000589335.1
|
USP32
|
ubiquitin specific peptidase 32 |
| chr3_-_18466026 | 16.83 |
ENST00000417717.2
|
SATB1
|
SATB homeobox 1 |
| chr13_-_72441315 | 16.64 |
ENST00000305425.4
ENST00000313174.7 ENST00000354591.4 |
DACH1
|
dachshund homolog 1 (Drosophila) |
| chr4_-_16900410 | 16.62 |
ENST00000304523.5
|
LDB2
|
LIM domain binding 2 |
| chr4_-_16900242 | 15.65 |
ENST00000502640.1
ENST00000506732.1 |
LDB2
|
LIM domain binding 2 |
| chr4_-_16900184 | 15.44 |
ENST00000515064.1
|
LDB2
|
LIM domain binding 2 |
| chr4_-_16900217 | 14.34 |
ENST00000441778.2
|
LDB2
|
LIM domain binding 2 |
| chr2_+_48757278 | 12.64 |
ENST00000404752.1
ENST00000406226.1 |
STON1
|
stonin 1 |
| chr14_-_54423529 | 12.14 |
ENST00000245451.4
ENST00000559087.1 |
BMP4
|
bone morphogenetic protein 4 |
| chr5_+_175298573 | 11.64 |
ENST00000512824.1
|
CPLX2
|
complexin 2 |
| chr1_+_61548225 | 11.32 |
ENST00000371187.3
|
NFIA
|
nuclear factor I/A |
| chr12_+_27396901 | 10.60 |
ENST00000541191.1
ENST00000389032.3 |
STK38L
|
serine/threonine kinase 38 like |
| chr2_+_148778570 | 10.39 |
ENST00000407073.1
|
MBD5
|
methyl-CpG binding domain protein 5 |
| chr10_-_126849588 | 10.16 |
ENST00000411419.2
|
CTBP2
|
C-terminal binding protein 2 |
| chr1_+_211432700 | 10.13 |
ENST00000452621.2
|
RCOR3
|
REST corepressor 3 |
| chr14_+_24867992 | 9.88 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
| chr8_-_22550815 | 9.76 |
ENST00000317216.2
|
EGR3
|
early growth response 3 |
| chr5_-_111092930 | 9.73 |
ENST00000257435.7
|
NREP
|
neuronal regeneration related protein |
| chr5_-_88179302 | 9.66 |
ENST00000504921.2
|
MEF2C
|
myocyte enhancer factor 2C |
| chr1_+_87797351 | 9.31 |
ENST00000370542.1
|
LMO4
|
LIM domain only 4 |
| chr13_-_72440901 | 9.22 |
ENST00000359684.2
|
DACH1
|
dachshund homolog 1 (Drosophila) |
| chr2_+_112656048 | 9.16 |
ENST00000295408.4
|
MERTK
|
c-mer proto-oncogene tyrosine kinase |
| chr2_+_112656176 | 9.12 |
ENST00000421804.2
ENST00000409780.1 |
MERTK
|
c-mer proto-oncogene tyrosine kinase |
| chr5_-_111093167 | 8.88 |
ENST00000446294.2
ENST00000419114.2 |
NREP
|
neuronal regeneration related protein |
| chr3_-_169381183 | 8.71 |
ENST00000494292.1
|
MECOM
|
MDS1 and EVI1 complex locus |
| chr3_+_20081515 | 8.68 |
ENST00000263754.4
|
KAT2B
|
K(lysine) acetyltransferase 2B |
| chr3_+_37903432 | 8.65 |
ENST00000443503.2
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
| chr22_+_51112800 | 8.61 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
| chr19_-_291133 | 8.11 |
ENST00000327790.3
|
PPAP2C
|
phosphatidic acid phosphatase type 2C |
| chr20_+_34742650 | 8.03 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chr4_-_90758118 | 8.01 |
ENST00000420646.2
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr4_+_30721968 | 7.94 |
ENST00000361762.2
|
PCDH7
|
protocadherin 7 |
| chr7_+_94023873 | 7.93 |
ENST00000297268.6
|
COL1A2
|
collagen, type I, alpha 2 |
| chr4_-_90758227 | 7.85 |
ENST00000506691.1
ENST00000394986.1 ENST00000506244.1 ENST00000394989.2 ENST00000394991.3 |
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor) |
| chr8_-_93107443 | 7.74 |
ENST00000360348.2
ENST00000520428.1 ENST00000518992.1 ENST00000520556.1 ENST00000518317.1 ENST00000521319.1 ENST00000521375.1 ENST00000518449.1 |
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr11_-_33891362 | 7.69 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
| chr5_-_111093406 | 7.62 |
ENST00000379671.3
|
NREP
|
neuronal regeneration related protein |
| chr6_-_16761678 | 7.54 |
ENST00000244769.4
ENST00000436367.1 |
ATXN1
|
ataxin 1 |
| chr2_-_217236750 | 7.49 |
ENST00000273067.4
|
MARCH4
|
membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase |
| chr5_-_111092873 | 7.44 |
ENST00000509025.1
ENST00000515855.1 |
NREP
|
neuronal regeneration related protein |
| chr19_-_291365 | 7.37 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
| chrX_-_119695279 | 7.24 |
ENST00000336592.6
|
CUL4B
|
cullin 4B |
| chr5_-_111093081 | 7.22 |
ENST00000453526.2
ENST00000509427.1 |
NREP
|
neuronal regeneration related protein |
| chr11_+_125034586 | 7.22 |
ENST00000298282.9
|
PKNOX2
|
PBX/knotted 1 homeobox 2 |
| chr1_+_211432775 | 7.18 |
ENST00000419091.2
|
RCOR3
|
REST corepressor 3 |
| chr5_+_68788594 | 7.11 |
ENST00000396442.2
ENST00000380766.2 |
OCLN
|
occludin |
| chr3_-_18466787 | 7.06 |
ENST00000338745.6
ENST00000450898.1 |
SATB1
|
SATB homeobox 1 |
| chr18_+_42260861 | 7.01 |
ENST00000282030.5
|
SETBP1
|
SET binding protein 1 |
| chr2_+_8822113 | 6.93 |
ENST00000396290.1
ENST00000331129.3 |
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
| chr1_+_61547894 | 6.88 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
| chr1_+_65775204 | 6.66 |
ENST00000371069.4
|
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6 |
| chrX_+_66764375 | 6.64 |
ENST00000374690.3
|
AR
|
androgen receptor |
| chr9_-_14314066 | 6.62 |
ENST00000397575.3
|
NFIB
|
nuclear factor I/B |
| chr5_-_111093340 | 6.53 |
ENST00000508870.1
|
NREP
|
neuronal regeneration related protein |
| chr20_+_34680620 | 6.31 |
ENST00000430276.1
ENST00000373950.2 ENST00000452261.1 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
| chr3_-_171177852 | 6.26 |
ENST00000284483.8
ENST00000475336.1 ENST00000357327.5 ENST00000460047.1 ENST00000488470.1 ENST00000470834.1 |
TNIK
|
TRAF2 and NCK interacting kinase |
| chr10_+_119301928 | 6.26 |
ENST00000553456.3
|
EMX2
|
empty spiracles homeobox 2 |
| chr4_-_18023350 | 6.17 |
ENST00000539056.1
ENST00000382226.5 ENST00000326877.4 |
LCORL
|
ligand dependent nuclear receptor corepressor-like |
| chr8_-_93107696 | 6.11 |
ENST00000436581.2
ENST00000520583.1 ENST00000519061.1 |
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr5_-_88178964 | 6.07 |
ENST00000513252.1
ENST00000508569.1 ENST00000510942.1 ENST00000506554.1 |
MEF2C
|
myocyte enhancer factor 2C |
| chr8_-_93107827 | 5.91 |
ENST00000520724.1
ENST00000518844.1 |
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr5_-_88179017 | 5.88 |
ENST00000514028.1
ENST00000514015.1 ENST00000503075.1 ENST00000437473.2 |
MEF2C
|
myocyte enhancer factor 2C |
| chr9_-_14313893 | 5.84 |
ENST00000380921.3
ENST00000380959.3 |
NFIB
|
nuclear factor I/B |
| chr18_-_22932080 | 5.82 |
ENST00000584787.1
ENST00000361524.3 ENST00000538137.2 |
ZNF521
|
zinc finger protein 521 |
| chr7_-_11871815 | 5.81 |
ENST00000423059.4
|
THSD7A
|
thrombospondin, type I, domain containing 7A |
| chr16_-_49890016 | 5.80 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
| chr12_+_93965451 | 5.79 |
ENST00000548537.1
|
SOCS2
|
suppressor of cytokine signaling 2 |
| chr20_-_45981138 | 5.72 |
ENST00000446994.2
|
ZMYND8
|
zinc finger, MYND-type containing 8 |
| chr1_-_20812690 | 5.71 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chrX_-_119694538 | 5.70 |
ENST00000371322.5
|
CUL4B
|
cullin 4B |
| chr1_+_210406121 | 5.61 |
ENST00000367012.3
|
SERTAD4
|
SERTA domain containing 4 |
| chr12_+_93965609 | 5.59 |
ENST00000549887.1
ENST00000551556.1 |
SOCS2
|
suppressor of cytokine signaling 2 |
| chr12_+_123319973 | 5.58 |
ENST00000253083.4
|
HIP1R
|
huntingtin interacting protein 1 related |
| chr12_-_56615693 | 5.56 |
ENST00000394013.2
ENST00000345093.4 ENST00000551711.1 ENST00000552656.1 |
RNF41
|
ring finger protein 41 |
| chr8_-_93115445 | 5.53 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
| chr7_-_156685841 | 5.51 |
ENST00000354505.4
ENST00000540390.1 |
LMBR1
|
limb development membrane protein 1 |
| chr11_-_130184555 | 5.49 |
ENST00000525842.1
|
ZBTB44
|
zinc finger and BTB domain containing 44 |
| chrX_+_73641286 | 5.39 |
ENST00000587091.1
|
SLC16A2
|
solute carrier family 16, member 2 (thyroid hormone transporter) |
| chr11_-_2906979 | 5.37 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
| chr4_-_102268484 | 5.32 |
ENST00000394853.4
|
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr6_+_17393888 | 5.32 |
ENST00000493172.1
ENST00000465994.1 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
| chr1_+_61547405 | 5.28 |
ENST00000371189.4
|
NFIA
|
nuclear factor I/A |
| chr19_-_17356697 | 5.23 |
ENST00000291442.3
|
NR2F6
|
nuclear receptor subfamily 2, group F, member 6 |
| chr4_-_149363662 | 5.18 |
ENST00000355292.3
ENST00000358102.3 |
NR3C2
|
nuclear receptor subfamily 3, group C, member 2 |
| chr4_+_41362796 | 5.12 |
ENST00000508501.1
ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
| chr2_+_182756615 | 5.12 |
ENST00000431877.2
ENST00000320370.7 |
SSFA2
|
sperm specific antigen 2 |
| chr14_-_21994525 | 5.09 |
ENST00000538754.1
|
SALL2
|
spalt-like transcription factor 2 |
| chr19_-_14201776 | 5.04 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr9_-_14313641 | 5.04 |
ENST00000380953.1
|
NFIB
|
nuclear factor I/B |
| chr9_+_133971909 | 4.97 |
ENST00000247291.3
ENST00000372302.1 ENST00000372300.1 ENST00000372298.1 |
AIF1L
|
allograft inflammatory factor 1-like |
| chr5_-_81046841 | 4.96 |
ENST00000509013.2
ENST00000505980.1 ENST00000509053.1 |
SSBP2
|
single-stranded DNA binding protein 2 |
| chr2_+_182756701 | 4.95 |
ENST00000409001.1
|
SSFA2
|
sperm specific antigen 2 |
| chr19_-_14201507 | 4.95 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr7_-_149470540 | 4.94 |
ENST00000302017.3
|
ZNF467
|
zinc finger protein 467 |
| chr1_-_53018654 | 4.94 |
ENST00000257177.4
ENST00000355809.4 ENST00000528642.1 ENST00000470626.1 ENST00000371544.3 |
ZCCHC11
|
zinc finger, CCHC domain containing 11 |
| chr2_+_182756915 | 4.91 |
ENST00000428267.2
|
SSFA2
|
sperm specific antigen 2 |
| chr5_+_175298674 | 4.89 |
ENST00000514150.1
|
CPLX2
|
complexin 2 |
| chr19_+_50194360 | 4.88 |
ENST00000323446.5
ENST00000392518.4 ENST00000598396.1 ENST00000598293.1 ENST00000354199.5 ENST00000405931.2 ENST00000602019.1 |
CPT1C
|
carnitine palmitoyltransferase 1C |
| chrX_-_54522558 | 4.88 |
ENST00000375135.3
|
FGD1
|
FYVE, RhoGEF and PH domain containing 1 |
| chrX_-_62974941 | 4.87 |
ENST00000374872.1
ENST00000253401.6 ENST00000374870.4 |
ARHGEF9
|
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
| chr7_+_30951461 | 4.85 |
ENST00000311813.4
|
AQP1
|
aquaporin 1 (Colton blood group) |
| chr12_-_53893227 | 4.79 |
ENST00000547488.1
|
MAP3K12
|
mitogen-activated protein kinase kinase kinase 12 |
| chr10_-_126849068 | 4.77 |
ENST00000494626.2
ENST00000337195.5 |
CTBP2
|
C-terminal binding protein 2 |
| chr4_-_102267953 | 4.75 |
ENST00000523694.2
ENST00000507176.1 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr6_-_32157947 | 4.74 |
ENST00000375050.4
|
PBX2
|
pre-B-cell leukemia homeobox 2 |
| chr2_-_165477971 | 4.74 |
ENST00000446413.2
|
GRB14
|
growth factor receptor-bound protein 14 |
| chr17_-_47841485 | 4.73 |
ENST00000506156.1
ENST00000240364.2 |
FAM117A
|
family with sequence similarity 117, member A |
| chr14_+_61788429 | 4.71 |
ENST00000332981.5
|
PRKCH
|
protein kinase C, eta |
| chr9_+_2015335 | 4.69 |
ENST00000349721.2
ENST00000357248.2 ENST00000450198.1 |
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
| chr19_+_45973120 | 4.67 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
| chr9_-_124991124 | 4.65 |
ENST00000394319.4
ENST00000340587.3 |
LHX6
|
LIM homeobox 6 |
| chr5_+_139027877 | 4.57 |
ENST00000302517.3
|
CXXC5
|
CXXC finger protein 5 |
| chr5_+_139028510 | 4.56 |
ENST00000502336.1
ENST00000520967.1 ENST00000511048.1 |
CXXC5
|
CXXC finger protein 5 |
| chr1_+_164528866 | 4.55 |
ENST00000420696.2
|
PBX1
|
pre-B-cell leukemia homeobox 1 |
| chr12_+_93963590 | 4.55 |
ENST00000340600.2
|
SOCS2
|
suppressor of cytokine signaling 2 |
| chr7_-_149470297 | 4.52 |
ENST00000484747.1
|
ZNF467
|
zinc finger protein 467 |
| chr1_+_61548374 | 4.49 |
ENST00000485903.2
ENST00000371185.2 ENST00000371184.2 |
NFIA
|
nuclear factor I/A |
| chr17_-_42277203 | 4.49 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
| chr1_+_61542922 | 4.47 |
ENST00000407417.3
|
NFIA
|
nuclear factor I/A |
| chr6_+_17393839 | 4.46 |
ENST00000489374.1
ENST00000378990.2 |
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
| chr5_-_171881362 | 4.45 |
ENST00000519643.1
|
SH3PXD2B
|
SH3 and PX domains 2B |
| chrX_-_70474499 | 4.45 |
ENST00000353904.2
|
ZMYM3
|
zinc finger, MYM-type 3 |
| chr10_+_35416223 | 4.44 |
ENST00000489321.1
ENST00000427847.2 ENST00000345491.3 ENST00000395895.2 ENST00000374728.3 ENST00000487132.1 |
CREM
|
cAMP responsive element modulator |
| chr10_+_35415978 | 4.39 |
ENST00000429130.3
ENST00000469949.2 ENST00000460270.1 |
CREM
|
cAMP responsive element modulator |
| chr7_+_89841024 | 4.37 |
ENST00000394626.1
|
STEAP2
|
STEAP family member 2, metalloreductase |
| chr9_-_20622478 | 4.35 |
ENST00000355930.6
ENST00000380338.4 |
MLLT3
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 |
| chr6_-_41909191 | 4.31 |
ENST00000512426.1
ENST00000372987.4 |
CCND3
|
cyclin D3 |
| chr11_-_130184470 | 4.30 |
ENST00000357899.4
ENST00000397753.1 |
ZBTB44
|
zinc finger and BTB domain containing 44 |
| chrX_-_70474910 | 4.29 |
ENST00000373988.1
ENST00000373998.1 |
ZMYM3
|
zinc finger, MYM-type 3 |
| chr1_+_211432593 | 4.27 |
ENST00000367006.4
|
RCOR3
|
REST corepressor 3 |
| chr4_-_102268628 | 4.24 |
ENST00000323055.6
ENST00000512215.1 ENST00000394854.3 |
PPP3CA
|
protein phosphatase 3, catalytic subunit, alpha isozyme |
| chr12_+_53443963 | 4.12 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
| chr13_-_110438914 | 4.10 |
ENST00000375856.3
|
IRS2
|
insulin receptor substrate 2 |
| chr4_-_138453606 | 4.07 |
ENST00000412923.2
ENST00000344876.4 ENST00000507846.1 ENST00000510305.1 |
PCDH18
|
protocadherin 18 |
| chr17_-_46690839 | 4.07 |
ENST00000498634.2
|
HOXB8
|
homeobox B8 |
| chr12_+_93964158 | 4.06 |
ENST00000549206.1
|
SOCS2
|
suppressor of cytokine signaling 2 |
| chr3_+_107244229 | 4.06 |
ENST00000456419.1
ENST00000402163.2 |
BBX
|
bobby sox homolog (Drosophila) |
| chr4_+_123747834 | 4.02 |
ENST00000264498.3
|
FGF2
|
fibroblast growth factor 2 (basic) |
| chr1_+_211433275 | 3.99 |
ENST00000367005.4
|
RCOR3
|
REST corepressor 3 |
| chr1_-_92351769 | 3.95 |
ENST00000212355.4
|
TGFBR3
|
transforming growth factor, beta receptor III |
| chr9_+_133971863 | 3.93 |
ENST00000372309.3
|
AIF1L
|
allograft inflammatory factor 1-like |
| chr11_+_5617858 | 3.89 |
ENST00000380097.3
|
TRIM6
|
tripartite motif containing 6 |
| chr10_-_105452917 | 3.87 |
ENST00000427662.2
|
SH3PXD2A
|
SH3 and PX domains 2A |
| chr12_-_118406028 | 3.86 |
ENST00000425217.1
|
KSR2
|
kinase suppressor of ras 2 |
| chr5_-_81046904 | 3.83 |
ENST00000515395.1
|
SSBP2
|
single-stranded DNA binding protein 2 |
| chr11_+_86748863 | 3.82 |
ENST00000340353.7
|
TMEM135
|
transmembrane protein 135 |
| chr1_+_61330931 | 3.81 |
ENST00000371191.1
|
NFIA
|
nuclear factor I/A |
| chr9_-_14314566 | 3.80 |
ENST00000397579.2
|
NFIB
|
nuclear factor I/B |
| chr12_-_42983478 | 3.80 |
ENST00000345127.3
ENST00000547113.1 |
PRICKLE1
|
prickle homolog 1 (Drosophila) |
| chr10_-_125851961 | 3.79 |
ENST00000346248.5
|
CHST15
|
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
| chr3_+_110790590 | 3.75 |
ENST00000485303.1
|
PVRL3
|
poliovirus receptor-related 3 |
| chr6_+_25279651 | 3.75 |
ENST00000329474.6
|
LRRC16A
|
leucine rich repeat containing 16A |
| chr1_+_82266053 | 3.75 |
ENST00000370715.1
ENST00000370713.1 ENST00000319517.6 ENST00000370717.2 ENST00000394879.1 ENST00000271029.4 ENST00000335786.5 |
LPHN2
|
latrophilin 2 |
| chr17_+_42634844 | 3.74 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
| chr16_-_15736881 | 3.74 |
ENST00000540441.2
|
KIAA0430
|
KIAA0430 |
| chr7_-_132262060 | 3.72 |
ENST00000359827.3
|
PLXNA4
|
plexin A4 |
| chr12_+_48513009 | 3.72 |
ENST00000359794.5
ENST00000551339.1 ENST00000395233.2 ENST00000548345.1 |
PFKM
|
phosphofructokinase, muscle |
| chr2_+_159313452 | 3.70 |
ENST00000389757.3
ENST00000389759.3 |
PKP4
|
plakophilin 4 |
| chr2_-_74667612 | 3.69 |
ENST00000305557.5
ENST00000233330.6 |
RTKN
|
rhotekin |
| chr17_-_58469687 | 3.67 |
ENST00000590133.1
|
USP32
|
ubiquitin specific peptidase 32 |
| chr16_+_29817841 | 3.66 |
ENST00000322945.6
ENST00000562337.1 ENST00000566906.2 ENST00000563402.1 ENST00000219782.6 |
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor) |
| chrX_-_117107680 | 3.66 |
ENST00000447671.2
ENST00000262820.3 |
KLHL13
|
kelch-like family member 13 |
| chr14_-_89883412 | 3.65 |
ENST00000557258.1
|
FOXN3
|
forkhead box N3 |
| chrX_-_63005405 | 3.63 |
ENST00000374878.1
ENST00000437457.2 |
ARHGEF9
|
Cdc42 guanine nucleotide exchange factor (GEF) 9 |
| chr22_-_37584321 | 3.62 |
ENST00000397110.2
ENST00000337843.2 |
C1QTNF6
|
C1q and tumor necrosis factor related protein 6 |
| chr9_-_14314518 | 3.62 |
ENST00000397581.2
|
NFIB
|
nuclear factor I/B |
| chrX_+_9754461 | 3.62 |
ENST00000380913.3
|
SHROOM2
|
shroom family member 2 |
| chr12_-_95044309 | 3.61 |
ENST00000261226.4
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
| chr11_+_5617330 | 3.59 |
ENST00000278302.5
ENST00000424369.1 ENST00000507320.1 ENST00000380107.1 |
TRIM6
|
tripartite motif containing 6 |
| chr3_+_12838161 | 3.58 |
ENST00000456430.2
|
CAND2
|
cullin-associated and neddylation-dissociated 2 (putative) |
| chr19_-_3029011 | 3.53 |
ENST00000590536.1
ENST00000587137.1 ENST00000455444.2 ENST00000262953.6 |
TLE2
|
transducin-like enhancer of split 2 (E(sp1) homolog, Drosophila) |
| chr10_-_33623826 | 3.52 |
ENST00000374867.2
|
NRP1
|
neuropilin 1 |
| chrX_+_152760397 | 3.51 |
ENST00000331595.4
ENST00000431891.1 |
BGN
|
biglycan |
| chr5_+_175299743 | 3.50 |
ENST00000502265.1
|
CPLX2
|
complexin 2 |
| chr15_+_96876340 | 3.50 |
ENST00000453270.2
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
| chr22_-_28197486 | 3.50 |
ENST00000302326.4
|
MN1
|
meningioma (disrupted in balanced translocation) 1 |
| chr3_+_54156664 | 3.48 |
ENST00000474759.1
ENST00000288197.5 |
CACNA2D3
|
calcium channel, voltage-dependent, alpha 2/delta subunit 3 |
| chr12_+_20522179 | 3.48 |
ENST00000359062.3
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited |
| chr2_+_45878790 | 3.44 |
ENST00000306156.3
|
PRKCE
|
protein kinase C, epsilon |
| chr6_-_110500905 | 3.44 |
ENST00000392587.2
|
WASF1
|
WAS protein family, member 1 |
| chr17_-_79008373 | 3.41 |
ENST00000577066.1
ENST00000573167.1 |
BAIAP2-AS1
|
BAIAP2 antisense RNA 1 (head to head) |
| chr4_+_156588249 | 3.41 |
ENST00000393832.3
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr19_+_34287751 | 3.40 |
ENST00000590771.1
ENST00000589786.1 ENST00000284006.6 ENST00000588881.1 |
KCTD15
|
potassium channel tetramerization domain containing 15 |
| chr1_-_33168336 | 3.39 |
ENST00000373484.3
|
SYNC
|
syncoilin, intermediate filament protein |
| chr10_-_33623564 | 3.38 |
ENST00000374875.1
ENST00000374822.4 |
NRP1
|
neuropilin 1 |
| chr20_+_42544782 | 3.37 |
ENST00000423191.2
ENST00000372999.1 |
TOX2
|
TOX high mobility group box family member 2 |
| chr15_-_71055769 | 3.36 |
ENST00000539319.1
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
| chr4_+_88928777 | 3.34 |
ENST00000237596.2
|
PKD2
|
polycystic kidney disease 2 (autosomal dominant) |
| chr1_+_212458834 | 3.34 |
ENST00000261461.2
|
PPP2R5A
|
protein phosphatase 2, regulatory subunit B', alpha |
| chr17_+_68165657 | 3.32 |
ENST00000243457.3
|
KCNJ2
|
potassium inwardly-rectifying channel, subfamily J, member 2 |
| chr15_-_34659349 | 3.31 |
ENST00000314891.6
|
LPCAT4
|
lysophosphatidylcholine acyltransferase 4 |
| chr13_+_35516390 | 3.30 |
ENST00000540320.1
ENST00000400445.3 ENST00000310336.4 |
NBEA
|
neurobeachin |
| chr1_+_84543734 | 3.30 |
ENST00000370689.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
| chr17_-_58469474 | 3.30 |
ENST00000300896.4
|
USP32
|
ubiquitin specific peptidase 32 |
| chr10_+_23384435 | 3.30 |
ENST00000376510.3
|
MSRB2
|
methionine sulfoxide reductase B2 |
| chr19_-_31840438 | 3.28 |
ENST00000240587.4
|
TSHZ3
|
teashirt zinc finger homeobox 3 |
| chr3_-_101232019 | 3.27 |
ENST00000394095.2
ENST00000394091.1 ENST00000394094.2 ENST00000358203.3 ENST00000348610.3 ENST00000314261.7 |
SENP7
|
SUMO1/sentrin specific peptidase 7 |
| chr4_+_102268904 | 3.27 |
ENST00000527564.1
ENST00000529296.1 |
AP001816.1
|
Uncharacterized protein |
| chrX_-_117107542 | 3.26 |
ENST00000371878.1
|
KLHL13
|
kelch-like family member 13 |
| chr10_+_112631547 | 3.25 |
ENST00000280154.7
ENST00000393104.2 |
PDCD4
|
programmed cell death 4 (neoplastic transformation inhibitor) |
Network of associatons between targets according to the STRING database.
First level regulatory network of MAZ_ZNF281_GTF2F1
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.4 | 16.3 | GO:0003277 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
| 5.4 | 21.6 | GO:0003138 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 4.8 | 14.3 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
| 3.8 | 26.4 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 3.4 | 17.0 | GO:2000470 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
| 3.1 | 3.1 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
| 3.0 | 24.3 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 2.7 | 10.6 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 2.5 | 9.8 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 2.4 | 7.1 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 2.3 | 13.8 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
| 2.3 | 6.8 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 2.2 | 6.7 | GO:0060599 | lateral sprouting involved in mammary gland duct morphogenesis(GO:0060599) |
| 2.1 | 6.3 | GO:0093001 | glycolysis from storage polysaccharide through glucose-1-phosphate(GO:0093001) |
| 2.0 | 66.4 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
| 1.9 | 19.1 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 1.8 | 7.4 | GO:0009956 | radial pattern formation(GO:0009956) |
| 1.8 | 9.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 1.8 | 7.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 1.7 | 10.4 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 1.7 | 15.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 1.7 | 5.0 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 1.7 | 5.0 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 1.7 | 9.9 | GO:1903756 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 1.6 | 9.8 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 1.6 | 6.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 1.5 | 3.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
| 1.5 | 4.5 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
| 1.5 | 7.4 | GO:0060939 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
| 1.4 | 2.7 | GO:0061009 | common bile duct development(GO:0061009) |
| 1.3 | 32.0 | GO:0072189 | ureter development(GO:0072189) |
| 1.3 | 2.7 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 1.3 | 3.9 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 1.3 | 14.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.3 | 7.6 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 1.3 | 3.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.3 | 3.8 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 1.2 | 3.7 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
| 1.2 | 3.7 | GO:0021793 | chemorepulsion of branchiomotor axon(GO:0021793) |
| 1.2 | 1.2 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
| 1.2 | 21.9 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 1.2 | 16.9 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 1.2 | 5.9 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 1.2 | 10.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 1.2 | 1.2 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 1.2 | 3.5 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 1.2 | 3.5 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
| 1.1 | 8.0 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 1.1 | 5.7 | GO:0060214 | endocardium formation(GO:0060214) |
| 1.1 | 3.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 1.1 | 3.3 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 1.1 | 3.3 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 1.1 | 4.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 1.0 | 3.1 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
| 1.0 | 9.4 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.0 | 3.1 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 1.0 | 3.1 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 1.0 | 4.1 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
| 1.0 | 6.1 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 1.0 | 11.5 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
| 1.0 | 20.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.9 | 3.8 | GO:2000691 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.9 | 2.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.9 | 2.8 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 0.9 | 1.9 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 0.9 | 0.9 | GO:0061010 | gall bladder development(GO:0061010) |
| 0.9 | 0.9 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.9 | 2.8 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.9 | 8.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
| 0.9 | 1.8 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.9 | 3.6 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.9 | 2.7 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
| 0.9 | 0.9 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
| 0.9 | 4.4 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.9 | 8.5 | GO:0015677 | copper ion import(GO:0015677) |
| 0.8 | 5.9 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.8 | 2.5 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.8 | 19.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.8 | 2.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.8 | 4.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
| 0.8 | 2.4 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.8 | 2.4 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.8 | 1.6 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 0.8 | 0.8 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.8 | 3.2 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.8 | 3.2 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.8 | 2.3 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.8 | 2.3 | GO:1900737 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.8 | 3.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.8 | 16.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.8 | 4.6 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.8 | 9.9 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
| 0.8 | 0.8 | GO:0060319 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) primitive erythrocyte differentiation(GO:0060319) |
| 0.8 | 3.0 | GO:0009183 | ADP biosynthetic process(GO:0006172) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.8 | 0.8 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.7 | 2.2 | GO:0003064 | regulation of heart rate by hormone(GO:0003064) |
| 0.7 | 4.4 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.7 | 4.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.7 | 2.2 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.7 | 0.7 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
| 0.7 | 9.2 | GO:0015074 | DNA integration(GO:0015074) |
| 0.7 | 4.9 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.7 | 2.8 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.7 | 1.4 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.7 | 3.5 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
| 0.7 | 2.1 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.7 | 4.8 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.7 | 3.4 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.7 | 2.1 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.7 | 1.4 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.7 | 2.7 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.7 | 0.7 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
| 0.7 | 0.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.7 | 2.0 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
| 0.7 | 3.3 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.7 | 5.2 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.7 | 1.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.6 | 1.3 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
| 0.6 | 0.6 | GO:0010159 | specification of organ position(GO:0010159) |
| 0.6 | 1.9 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.6 | 3.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.6 | 3.8 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
| 0.6 | 2.5 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.6 | 0.6 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
| 0.6 | 1.2 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.6 | 1.2 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 0.6 | 2.5 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.6 | 3.7 | GO:0010748 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
| 0.6 | 3.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.6 | 6.7 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.6 | 6.7 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
| 0.6 | 1.8 | GO:0050894 | determination of affect(GO:0050894) |
| 0.6 | 3.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.6 | 3.6 | GO:1901908 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.6 | 3.5 | GO:0030421 | defecation(GO:0030421) |
| 0.6 | 4.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.6 | 5.3 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.6 | 1.8 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.6 | 3.5 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 0.6 | 2.3 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 0.6 | 1.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.6 | 4.0 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.6 | 2.3 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.6 | 8.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.6 | 2.9 | GO:1904016 | response to Thyroglobulin triiodothyronine(GO:1904016) |
| 0.6 | 1.7 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 0.6 | 2.3 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.6 | 1.7 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.6 | 3.4 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.6 | 3.3 | GO:0031442 | positive regulation of mRNA 3'-end processing(GO:0031442) regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.6 | 2.2 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.5 | 2.7 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 0.5 | 1.6 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.5 | 2.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.5 | 1.6 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
| 0.5 | 1.6 | GO:0070839 | divalent metal ion export(GO:0070839) |
| 0.5 | 1.6 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
| 0.5 | 3.2 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.5 | 1.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.5 | 6.9 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.5 | 3.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.5 | 2.1 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.5 | 6.8 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
| 0.5 | 1.6 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.5 | 2.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.5 | 3.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.5 | 4.7 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
| 0.5 | 1.0 | GO:0061074 | regulation of neural retina development(GO:0061074) |
| 0.5 | 3.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.5 | 2.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.5 | 0.5 | GO:1990868 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 0.5 | 1.5 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 0.5 | 3.0 | GO:0046959 | habituation(GO:0046959) |
| 0.5 | 1.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.5 | 2.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.5 | 3.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
| 0.5 | 2.4 | GO:0031296 | B cell costimulation(GO:0031296) |
| 0.5 | 0.5 | GO:0042713 | sperm ejaculation(GO:0042713) |
| 0.5 | 1.0 | GO:0010579 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.5 | 1.4 | GO:0050960 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
| 0.5 | 1.9 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
| 0.5 | 1.4 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.5 | 4.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.5 | 0.5 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.5 | 1.9 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.5 | 0.9 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.5 | 0.9 | GO:0097676 | histone H3-K36 dimethylation(GO:0097676) |
| 0.5 | 1.4 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.5 | 1.4 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.5 | 1.4 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.5 | 1.4 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.5 | 2.7 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.5 | 1.8 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.5 | 0.5 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.4 | 2.7 | GO:0035973 | aggrephagy(GO:0035973) |
| 0.4 | 0.9 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 0.4 | 1.3 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.4 | 2.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 0.4 | 0.4 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.4 | 1.7 | GO:0001808 | negative regulation of type IV hypersensitivity(GO:0001808) |
| 0.4 | 1.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.4 | 6.5 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.4 | 1.7 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.4 | 2.6 | GO:0006311 | meiotic gene conversion(GO:0006311) |
| 0.4 | 12.4 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.4 | 4.2 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.4 | 9.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.4 | 3.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.4 | 0.8 | GO:2000861 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.4 | 1.6 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.4 | 4.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.4 | 1.2 | GO:0002371 | dendritic cell cytokine production(GO:0002371) |
| 0.4 | 5.9 | GO:0015871 | choline transport(GO:0015871) |
| 0.4 | 0.4 | GO:0035822 | gene conversion(GO:0035822) |
| 0.4 | 3.5 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.4 | 3.9 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 0.4 | 4.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.4 | 0.8 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.4 | 1.2 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 0.4 | 0.4 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.4 | 2.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.4 | 0.8 | GO:0007497 | posterior midgut development(GO:0007497) |
| 0.4 | 0.8 | GO:0042701 | progesterone secretion(GO:0042701) |
| 0.4 | 3.1 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.4 | 3.1 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.4 | 1.5 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 0.4 | 0.4 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.4 | 1.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.4 | 1.9 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
| 0.4 | 3.0 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.4 | 2.6 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.4 | 3.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.4 | 0.4 | GO:0072209 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
| 0.4 | 0.4 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
| 0.4 | 0.4 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
| 0.4 | 1.1 | GO:0046081 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 0.4 | 1.1 | GO:1990519 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.4 | 1.1 | GO:0072720 | cellular response to mycotoxin(GO:0036146) response to dithiothreitol(GO:0072720) |
| 0.4 | 1.5 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.4 | 0.4 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.4 | 1.5 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
| 0.4 | 1.8 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.4 | 4.8 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.4 | 2.9 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.4 | 1.1 | GO:1905203 | regulation of connective tissue replacement(GO:1905203) |
| 0.4 | 1.1 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 0.4 | 3.6 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.4 | 2.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.4 | 2.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.4 | 1.8 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.4 | 4.2 | GO:0033227 | dsRNA transport(GO:0033227) |
| 0.3 | 1.0 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.3 | 1.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.3 | 0.7 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.3 | 1.7 | GO:0030070 | insulin processing(GO:0030070) |
| 0.3 | 1.4 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.3 | 3.1 | GO:1900272 | negative regulation of long-term synaptic potentiation(GO:1900272) |
| 0.3 | 1.7 | GO:0003174 | mitral valve development(GO:0003174) |
| 0.3 | 1.0 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 0.3 | 1.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
| 0.3 | 1.7 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
| 0.3 | 1.7 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.3 | 1.3 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.3 | 5.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.3 | 0.3 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 0.3 | 1.0 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
| 0.3 | 6.0 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
| 0.3 | 1.3 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 0.3 | 10.6 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.3 | 4.9 | GO:0007379 | segment specification(GO:0007379) |
| 0.3 | 2.3 | GO:1990403 | embryonic brain development(GO:1990403) |
| 0.3 | 1.0 | GO:1990641 | response to iron ion starvation(GO:1990641) |
| 0.3 | 1.0 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 0.3 | 7.4 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.3 | 2.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 | 3.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.3 | 1.9 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.3 | 0.9 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.3 | 3.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.3 | 2.2 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.3 | 3.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.3 | 0.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.3 | 0.9 | GO:0014876 | negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.3 | 0.3 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) |
| 0.3 | 2.8 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.3 | 1.8 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.3 | 6.7 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 | 0.9 | GO:0060023 | soft palate development(GO:0060023) |
| 0.3 | 0.9 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.3 | 1.8 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
| 0.3 | 7.6 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.3 | 0.9 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.3 | 1.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.3 | 14.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.3 | 0.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.3 | 0.3 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.3 | 0.6 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.3 | 1.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.3 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
| 0.3 | 0.3 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.3 | 0.9 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.3 | 14.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.3 | 0.3 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
| 0.3 | 0.6 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.3 | 1.2 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.3 | 2.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.3 | 1.1 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
| 0.3 | 0.6 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 0.3 | 1.7 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 0.3 | 4.8 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
| 0.3 | 1.1 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.3 | 2.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.3 | 1.4 | GO:0097017 | renal protein absorption(GO:0097017) |
| 0.3 | 5.9 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.3 | 1.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.3 | 0.8 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.3 | 0.6 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.3 | 1.7 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.3 | 0.6 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.3 | 3.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.3 | 1.1 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.3 | 1.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.3 | 3.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.3 | 4.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.3 | 0.8 | GO:0031247 | actin rod assembly(GO:0031247) |
| 0.3 | 0.8 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.3 | 0.8 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 0.3 | 3.8 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
| 0.3 | 3.5 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.3 | 1.3 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.3 | 2.9 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.3 | 1.3 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.3 | 4.2 | GO:2000194 | regulation of female gonad development(GO:2000194) |
| 0.3 | 1.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.3 | 0.3 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 0.3 | 0.3 | GO:0042223 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) |
| 0.3 | 2.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.3 | 1.3 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.3 | 2.9 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.3 | 4.4 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.3 | 2.1 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.3 | 5.7 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.3 | 1.3 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.3 | 0.8 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.3 | 0.8 | GO:0002786 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.3 | 0.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.3 | 1.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 0.3 | 0.8 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.3 | 1.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.2 | 3.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.2 | 0.7 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.2 | 2.5 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
| 0.2 | 0.7 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.2 | 0.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 | 1.0 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.2 | 1.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.2 | 0.2 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.2 | 0.7 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 0.2 | 0.7 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.2 | 1.4 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.2 | 1.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.2 | 1.0 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.2 | 1.4 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.2 | 2.6 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 | 4.6 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.2 | 2.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.2 | 1.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.2 | 1.0 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 | 1.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.2 | 0.7 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.2 | 0.2 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
| 0.2 | 0.9 | GO:0034182 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
| 0.2 | 9.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.2 | 0.7 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 0.2 | 0.9 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.2 | 1.2 | GO:0019075 | virus maturation(GO:0019075) |
| 0.2 | 0.9 | GO:1902462 | mesenchymal stem cell proliferation(GO:0097168) regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.2 | 0.5 | GO:0060584 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.2 | 3.2 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
| 0.2 | 2.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.2 | 0.7 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
| 0.2 | 2.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.2 | 1.6 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.2 | 0.7 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
| 0.2 | 3.1 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
| 0.2 | 1.1 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 0.2 | 1.1 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
| 0.2 | 4.6 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
| 0.2 | 1.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 | 2.0 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.2 | 1.1 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
| 0.2 | 0.9 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
| 0.2 | 3.7 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.2 | 0.7 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.2 | 0.4 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.2 | 2.0 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.2 | 1.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.2 | 0.4 | GO:0035739 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
| 0.2 | 0.4 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.2 | 3.0 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 | 5.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 | 1.1 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.2 | 1.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.2 | 0.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
| 0.2 | 1.3 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.2 | 0.4 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.2 | 0.6 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.2 | 0.6 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 | 4.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
| 0.2 | 2.1 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.2 | 0.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 | 1.5 | GO:0019086 | late viral transcription(GO:0019086) |
| 0.2 | 1.5 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.2 | 0.6 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.2 | 7.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.2 | 0.8 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.2 | 0.4 | GO:0042938 | dipeptide transport(GO:0042938) |
| 0.2 | 0.2 | GO:0090030 | regulation of steroid hormone biosynthetic process(GO:0090030) |
| 0.2 | 1.0 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.2 | 2.7 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 0.6 | GO:1904387 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 0.2 | 0.4 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
| 0.2 | 0.8 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
| 0.2 | 0.6 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.2 | 0.4 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.2 | 1.0 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 0.2 | 1.6 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 | 0.8 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
| 0.2 | 8.4 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.2 | 1.8 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.2 | 0.6 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 0.2 | 0.4 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
| 0.2 | 0.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.2 | 2.2 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.2 | 1.2 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.2 | 3.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.2 | 2.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.2 | 0.8 | GO:0048875 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
| 0.2 | 1.6 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.2 | 1.2 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 | 0.6 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
| 0.2 | 0.4 | GO:0006404 | RNA import into nucleus(GO:0006404) |
| 0.2 | 4.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.2 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 0.2 | 0.6 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.2 | 0.8 | GO:0045759 | negative regulation of action potential(GO:0045759) |
| 0.2 | 3.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.2 | 3.5 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
| 0.2 | 0.2 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.2 | 0.6 | GO:0048627 | myoblast development(GO:0048627) |
| 0.2 | 0.8 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.2 | 0.8 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.2 | 3.6 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.2 | 0.2 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
| 0.2 | 0.8 | GO:0060736 | prostate gland growth(GO:0060736) |
| 0.2 | 3.0 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.2 | 0.9 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.2 | 1.1 | GO:0072079 | nephron tubule formation(GO:0072079) |
| 0.2 | 2.2 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.2 | 0.7 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.2 | 0.6 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.2 | 4.4 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.2 | 0.5 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.2 | 1.1 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.2 | 0.2 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.2 | 0.5 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
| 0.2 | 0.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
| 0.2 | 4.0 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.2 | 1.6 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
| 0.2 | 0.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.2 | 1.4 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.2 | 0.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 0.2 | 0.2 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
| 0.2 | 0.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 | 0.7 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.2 | 0.7 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.2 | 1.1 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
| 0.2 | 0.9 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.2 | 0.5 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 0.2 | 3.7 | GO:0009650 | UV protection(GO:0009650) |
| 0.2 | 1.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
| 0.2 | 3.2 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.2 | 1.9 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.2 | 0.5 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 | 1.4 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.2 | 0.5 | GO:1902771 | protein retention in Golgi apparatus(GO:0045053) regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 0.2 | 0.7 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 0.2 | 2.6 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.2 | 1.4 | GO:0021924 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.2 | 2.6 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 | 1.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.2 | 0.5 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.2 | 0.5 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.2 | 0.5 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
| 0.2 | 0.8 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.2 | 0.7 | GO:0030242 | pexophagy(GO:0030242) |
| 0.2 | 1.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.2 | 0.3 | GO:0070101 | positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
| 0.2 | 1.2 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
| 0.2 | 1.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.2 | 0.7 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.2 | 0.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.2 | 1.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.2 | 0.6 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 | 1.9 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 | 1.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.2 | 1.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
| 0.2 | 0.5 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 0.2 | 0.8 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.2 | 0.5 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.2 | 0.5 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.2 | 0.3 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.2 | 0.6 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.2 | 0.9 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.2 | 0.5 | GO:0033967 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 0.2 | 0.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.2 | 0.2 | GO:2000506 | negative regulation of energy homeostasis(GO:2000506) |
| 0.2 | 0.3 | GO:1901376 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
| 0.2 | 1.1 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.2 | 0.5 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.2 | 0.3 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.2 | 1.7 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
| 0.1 | 0.6 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.1 | 1.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.1 | 0.1 | GO:0032898 | neurotrophin production(GO:0032898) |
| 0.1 | 2.2 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
| 0.1 | 1.8 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 | 0.7 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.1 | 0.4 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
| 0.1 | 1.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 1.7 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.1 | 0.6 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
| 0.1 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.1 | 1.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.1 | 0.4 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
| 0.1 | 0.7 | GO:0015862 | uridine transport(GO:0015862) |
| 0.1 | 1.7 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.1 | 0.3 | GO:1901671 | positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
| 0.1 | 6.1 | GO:0045103 | intermediate filament-based process(GO:0045103) |
| 0.1 | 0.6 | GO:0039506 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.1 | 2.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.1 | 0.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 | 1.0 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 | 1.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 0.1 | 1.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 2.7 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 0.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.1 | 0.4 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.1 | 1.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
| 0.1 | 0.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.1 | 5.0 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
| 0.1 | 0.3 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 0.1 | 0.4 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
| 0.1 | 0.7 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.1 | 0.1 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
| 0.1 | 0.5 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.1 | 0.4 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 0.1 | 2.3 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.1 | 0.4 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
| 0.1 | 0.9 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 | 1.4 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
| 0.1 | 1.4 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.1 | 0.4 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
| 0.1 | 0.1 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
| 0.1 | 2.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.1 | 0.3 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.1 | 1.6 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
| 0.1 | 0.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.1 | 1.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.1 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 | 0.5 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.1 | 2.0 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
| 0.1 | 0.5 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.1 | 0.8 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 | 0.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 2.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 | 0.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.1 | 0.6 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.1 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.1 | 0.1 | GO:0001963 | synaptic transmission, dopaminergic(GO:0001963) |
| 0.1 | 2.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.1 | 2.9 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.1 | 0.3 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 | 1.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 2.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.1 | 2.1 | GO:0005979 | regulation of glycogen biosynthetic process(GO:0005979) regulation of glucan biosynthetic process(GO:0010962) |
| 0.1 | 0.6 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 0.1 | 0.2 | GO:0032097 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
| 0.1 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
| 0.1 | 3.5 | GO:0048265 | response to pain(GO:0048265) |
| 0.1 | 0.1 | GO:2000410 | regulation of thymocyte migration(GO:2000410) |
| 0.1 | 0.6 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 0.1 | 1.5 | GO:0006293 | nucleotide-excision repair, preincision complex stabilization(GO:0006293) |
| 0.1 | 0.7 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 | 3.8 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.1 | 2.7 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 1.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.1 | 0.6 | GO:0043585 | nose morphogenesis(GO:0043585) alveolar primary septum development(GO:0061143) |
| 0.1 | 0.4 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.1 | 1.0 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.1 | 11.6 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 | 1.2 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 | 0.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.1 | 3.9 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.1 | 1.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 | 0.8 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.1 | 0.6 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.1 | 0.4 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 | 0.6 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.1 | 0.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 | 5.1 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 | 4.8 | GO:0007031 | peroxisome organization(GO:0007031) |
| 0.1 | 0.1 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 | 0.3 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.1 | 2.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 1.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 | 0.3 | GO:0060734 | positive regulation of translational initiation in response to stress(GO:0032058) regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.1 | 0.7 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.1 | 0.8 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 0.1 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 | 0.8 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.1 | 0.3 | GO:0014842 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.1 | 0.8 | GO:0045007 | depurination(GO:0045007) |
| 0.1 | 0.4 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.1 | 0.4 | GO:0005985 | sucrose metabolic process(GO:0005985) sucrose biosynthetic process(GO:0005986) |
| 0.1 | 0.2 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 | 0.1 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.1 | 0.9 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 | 1.2 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 0.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 2.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 0.3 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.1 | 0.3 | GO:0002752 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) cell surface pattern recognition receptor signaling pathway(GO:0002752) |
| 0.1 | 0.3 | GO:0090189 | regulation of branching involved in ureteric bud morphogenesis(GO:0090189) |
| 0.1 | 1.4 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.1 | 4.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.1 | 2.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 | 1.8 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 1.5 | GO:0090128 | regulation of synapse maturation(GO:0090128) |
| 0.1 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.1 | 0.3 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.1 | 0.3 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.1 | 0.6 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 | 1.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.1 | 4.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.1 | 1.0 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
| 0.1 | 0.3 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
| 0.1 | 0.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 | 1.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 | 9.5 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.1 | 0.9 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 3.0 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 | 0.3 | GO:0031456 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.1 | 0.3 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 | 0.2 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.1 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
| 0.1 | 0.5 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
| 0.1 | 0.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.1 | 0.2 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
| 0.1 | 1.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.1 | 1.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.4 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 | 0.2 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.1 | 0.4 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.1 | 0.2 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
| 0.1 | 0.3 | GO:0050893 | sensory processing(GO:0050893) |
| 0.1 | 0.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.1 | 0.3 | GO:0038001 | paracrine signaling(GO:0038001) |
| 0.1 | 0.4 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 | 0.6 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 0.2 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.1 | 0.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 | 0.1 | GO:0006114 | glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.1 | 0.2 | GO:0046219 | indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.1 | 0.2 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 | 0.8 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
| 0.1 | 0.3 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
| 0.1 | 0.4 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
| 0.1 | 0.3 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.1 | 0.1 | GO:0034241 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 0.1 | 1.8 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.1 | 0.4 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.1 | 0.3 | GO:1901535 | regulation of DNA demethylation(GO:1901535) |
| 0.1 | 0.2 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.1 | 0.3 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.1 | 0.5 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.1 | 0.9 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 | 0.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
| 0.1 | 0.4 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.1 | 0.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.1 | 0.8 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.1 | 2.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
| 0.1 | 0.3 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.1 | 0.3 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
| 0.1 | 1.7 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.1 | 0.4 | GO:0032648 | regulation of interferon-beta production(GO:0032648) |
| 0.1 | 0.3 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 0.1 | 1.4 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.1 | 0.8 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 | 0.1 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 | 0.1 | GO:0032494 | response to peptidoglycan(GO:0032494) |
| 0.1 | 1.0 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 0.1 | 0.1 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 | 1.7 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.1 | 0.3 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.1 | 0.5 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 0.1 | 1.4 | GO:0006536 | glutamate metabolic process(GO:0006536) |
| 0.1 | 0.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.1 | 1.8 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
| 0.1 | 0.2 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.1 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
| 0.1 | 0.4 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.1 | 0.3 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.1 | 1.5 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.1 | 2.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.1 | 0.2 | GO:0043486 | histone exchange(GO:0043486) |
| 0.1 | 0.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.1 | 0.2 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 | 0.2 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 | 0.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 | 0.9 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.1 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.1 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 | 0.2 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.1 | 0.3 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.1 | 0.2 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.1 | 1.2 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 0.5 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
| 0.1 | 0.9 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.1 | 0.4 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.1 | 0.5 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 0.4 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.1 | 0.5 | GO:0070977 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
| 0.1 | 0.2 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.1 | 0.6 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 0.1 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
| 0.1 | 0.6 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.1 | 6.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.1 | 0.2 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 | 0.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.1 | 0.3 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.1 | 0.1 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 0.6 | GO:1901678 | iron coordination entity transport(GO:1901678) |
| 0.1 | 0.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.1 | 0.1 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
| 0.1 | 1.3 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 | 0.2 | GO:0060296 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.1 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
| 0.1 | 0.2 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.1 | 0.1 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.1 | 0.3 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.1 | 1.4 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 | 0.1 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.1 | 0.1 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.1 | 1.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.1 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.1 | 0.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.1 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 | 0.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 | 0.5 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
| 0.1 | 0.4 | GO:0032049 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
| 0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 | 0.2 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.1 | 0.7 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 0.1 | 0.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 0.6 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.1 | 0.9 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.1 | 0.4 | GO:1902996 | regulation of neurofibrillary tangle assembly(GO:1902996) |
| 0.1 | 0.3 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 0.4 | GO:1990539 | fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.1 | 0.7 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
| 0.1 | 1.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 | 0.5 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 0.1 | 1.2 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.1 | 2.5 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.1 | 0.7 | GO:0009648 | photoperiodism(GO:0009648) |
| 0.1 | 0.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 0.1 | GO:0097107 | postsynaptic density assembly(GO:0097107) |
| 0.1 | 0.8 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
| 0.1 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.1 | 0.2 | GO:0048867 | stem cell fate commitment(GO:0048865) stem cell fate determination(GO:0048867) |
| 0.1 | 0.2 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.1 | 0.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 | 0.2 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.1 | 0.3 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.1 | 0.7 | GO:0000050 | urea cycle(GO:0000050) |
| 0.1 | 1.8 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 0.1 | 0.4 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 0.1 | 0.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.3 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 | 0.1 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.1 | 0.4 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 | 0.4 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.1 | 0.2 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.1 | 0.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.1 | 0.1 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 | 0.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.1 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 | 8.9 | GO:0031424 | keratinization(GO:0031424) |
| 0.1 | 0.5 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.1 | 0.2 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.1 | 0.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.1 | 0.8 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.1 | 0.8 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 | 0.2 | GO:1900225 | regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
| 0.1 | 0.5 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
| 0.1 | 0.2 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.1 | 1.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.1 | 0.1 | GO:0046832 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.0 | 0.3 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.0 | 0.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.0 | 1.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.0 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.0 | 0.2 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 0.0 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 0.0 | 1.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 | 1.1 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.0 | 0.1 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.0 | 0.2 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.0 | 1.0 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.0 | 0.1 | GO:1903677 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
| 0.0 | 0.0 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.0 | 0.0 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
| 0.0 | 0.2 | GO:0042335 | cuticle development(GO:0042335) |
| 0.0 | 0.1 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.0 | 1.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 | 0.2 | GO:0019323 | pentose catabolic process(GO:0019323) |
| 0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.0 | 2.3 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.0 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 | 0.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.0 | 0.1 | GO:0015743 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
| 0.0 | 0.6 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.0 | 0.6 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.0 | 0.4 | GO:0009304 | tRNA transcription(GO:0009304) |
| 0.0 | 0.1 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.0 | 0.1 | GO:1903027 | regulation of opsonization(GO:1903027) |
| 0.0 | 0.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.0 | 0.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.0 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.0 | 0.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.0 | 1.2 | GO:2001259 | positive regulation of cation channel activity(GO:2001259) |
| 0.0 | 0.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 | 0.7 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.0 | 0.2 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
| 0.0 | 0.2 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 | 0.2 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.0 | 0.5 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.0 | 0.1 | GO:0006983 | ER overload response(GO:0006983) |
| 0.0 | 0.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.0 | 2.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 | 0.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.0 | 0.2 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.0 | 0.1 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) cellular response to amine stimulus(GO:0071418) |
| 0.0 | 0.1 | GO:0072141 | renal interstitial fibroblast development(GO:0072141) |
| 0.0 | 0.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.0 | 0.3 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.0 | 0.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.0 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
| 0.0 | 0.6 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
| 0.0 | 0.0 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.0 | 0.6 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.2 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.0 | 0.6 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.0 | 0.1 | GO:0002586 | regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
| 0.0 | 0.4 | GO:0072575 | hepatocyte proliferation(GO:0072574) epithelial cell proliferation involved in liver morphogenesis(GO:0072575) |
| 0.0 | 0.2 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.0 | 0.1 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.0 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 | 0.1 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
| 0.0 | 0.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 0.0 | 0.1 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
| 0.0 | 0.1 | GO:0035565 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
| 0.0 | 0.3 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.0 | 0.4 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.1 | GO:0034127 | regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.0 | 0.1 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.0 | 0.6 | GO:1990089 | response to nerve growth factor(GO:1990089) |
| 0.0 | 0.0 | GO:0060068 | vagina development(GO:0060068) |
| 0.0 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
| 0.0 | 0.2 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.0 | 0.2 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
| 0.0 | 0.5 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.0 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 | 0.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.5 | GO:0003341 | cilium movement(GO:0003341) |
| 0.0 | 1.2 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.3 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.0 | 0.0 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
| 0.0 | 0.1 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.0 | 0.1 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
| 0.0 | 0.1 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.0 | 0.1 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 0.0 | 0.1 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.0 | 0.2 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 | 0.8 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.0 | 0.3 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
| 0.0 | 0.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.0 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.0 | 0.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.0 | 0.1 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.0 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
| 0.0 | 0.1 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.0 | 0.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 | 0.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.0 | 0.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
| 0.0 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.0 | 1.4 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.0 | 0.1 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) |
| 0.0 | 1.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.0 | 0.1 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.0 | 0.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.0 | 0.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.0 | 1.5 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.0 | 0.2 | GO:0044597 | polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.0 | 0.3 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.0 | 0.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 | 0.1 | GO:0015705 | iodide transport(GO:0015705) |
| 0.0 | 0.3 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 | 3.5 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.0 | 0.5 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.0 | 0.0 | GO:0001967 | suckling behavior(GO:0001967) |
| 0.0 | 0.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.0 | 0.4 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.0 | 1.0 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
| 0.0 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.0 | 0.2 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.0 | 0.2 | GO:0031297 | replication fork processing(GO:0031297) |
| 0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
| 0.0 | 0.4 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 | 0.1 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.0 | 0.2 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.0 | 0.1 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.0 | 0.1 | GO:0048539 | bone marrow development(GO:0048539) |
| 0.0 | 1.2 | GO:0001895 | retina homeostasis(GO:0001895) |
| 0.0 | 0.2 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.0 | 0.1 | GO:0015791 | polyol transport(GO:0015791) |
| 0.0 | 0.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.0 | 0.3 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
| 0.0 | 0.0 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 | 0.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.0 | 0.1 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 | 0.2 | GO:0034311 | diol metabolic process(GO:0034311) |
| 0.0 | 0.3 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 | 0.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.0 | 0.1 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.0 | 0.1 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 | 0.1 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.0 | 0.1 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.0 | 0.8 | GO:0006446 | regulation of translational initiation(GO:0006446) |
| 0.0 | 0.2 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
| 0.0 | 0.0 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 | 0.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.0 | 0.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 | 0.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.0 | 0.0 | GO:0046066 | dADP phosphorylation(GO:0006174) dGDP phosphorylation(GO:0006186) AMP phosphorylation(GO:0006756) purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) dGDP metabolic process(GO:0046066) CDP phosphorylation(GO:0061508) dAMP phosphorylation(GO:0061565) CMP phosphorylation(GO:0061566) dCMP phosphorylation(GO:0061567) GDP phosphorylation(GO:0061568) UDP phosphorylation(GO:0061569) dCDP phosphorylation(GO:0061570) TDP phosphorylation(GO:0061571) |
| 0.0 | 0.1 | GO:0009447 | putrescine catabolic process(GO:0009447) |
| 0.0 | 0.0 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.0 | 0.0 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.0 | 0.0 | GO:0089712 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
| 0.0 | 0.1 | GO:0000732 | strand displacement(GO:0000732) |
| 0.0 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.0 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.0 | 0.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.0 | 0.1 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.0 | 0.0 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
| 0.0 | 0.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 | 0.1 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.0 | 0.2 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.1 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.0 | 0.2 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.0 | 0.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 1.8 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.5 | 20.0 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 2.4 | 7.1 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 1.9 | 14.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 1.5 | 13.8 | GO:0005955 | calcineurin complex(GO:0005955) |
| 1.4 | 24.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 1.2 | 16.0 | GO:0097470 | ribbon synapse(GO:0097470) |
| 1.1 | 4.5 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 1.0 | 3.1 | GO:0048179 | activin receptor complex(GO:0048179) |
| 1.0 | 3.1 | GO:0055028 | cortical microtubule(GO:0055028) |
| 1.0 | 11.3 | GO:0097443 | sorting endosome(GO:0097443) |
| 1.0 | 7.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 1.0 | 3.0 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 1.0 | 4.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.9 | 2.7 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.9 | 30.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.8 | 7.6 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.8 | 2.5 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.8 | 12.2 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.8 | 2.3 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
| 0.7 | 5.2 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.7 | 4.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.7 | 8.0 | GO:0035102 | PRC1 complex(GO:0035102) |
| 0.7 | 7.9 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 0.7 | 3.6 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.7 | 2.8 | GO:0031251 | PAN complex(GO:0031251) |
| 0.7 | 2.7 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.7 | 6.8 | GO:0016589 | NURF complex(GO:0016589) |
| 0.6 | 7.7 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.6 | 1.9 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 0.6 | 2.5 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.6 | 1.9 | GO:0032302 | MutSbeta complex(GO:0032302) |
| 0.6 | 2.4 | GO:0031673 | H zone(GO:0031673) |
| 0.6 | 3.4 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.5 | 18.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.5 | 21.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.5 | 3.4 | GO:1990393 | 3M complex(GO:1990393) |
| 0.5 | 12.8 | GO:0010369 | chromocenter(GO:0010369) |
| 0.5 | 1.9 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.5 | 10.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.5 | 1.4 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 0.4 | 4.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.4 | 1.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.4 | 1.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.4 | 3.8 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.4 | 1.7 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.4 | 1.3 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.4 | 1.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.4 | 5.8 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.4 | 2.1 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 0.4 | 5.3 | GO:0032039 | integrator complex(GO:0032039) |
| 0.4 | 6.5 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.4 | 10.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.4 | 1.2 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.4 | 10.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.4 | 0.8 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.4 | 1.5 | GO:0097513 | myosin II filament(GO:0097513) |
| 0.4 | 1.5 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.4 | 15.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.4 | 4.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
| 0.4 | 1.4 | GO:0097224 | sperm connecting piece(GO:0097224) |
| 0.4 | 1.8 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.4 | 1.1 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 0.3 | 1.0 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.3 | 3.4 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.3 | 1.3 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.3 | 1.3 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.3 | 3.3 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.3 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.3 | 4.1 | GO:0045179 | apical cortex(GO:0045179) |
| 0.3 | 2.2 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.3 | 9.7 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.3 | 3.6 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.3 | 1.7 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.3 | 6.9 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.3 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.3 | 2.3 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.3 | 3.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.3 | 2.3 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.3 | 0.8 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.3 | 16.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.3 | 134.7 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.3 | 1.4 | GO:0032449 | CBM complex(GO:0032449) |
| 0.3 | 4.6 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.3 | 1.4 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.3 | 0.8 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 0.3 | 2.6 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.3 | 6.6 | GO:0097546 | ciliary base(GO:0097546) |
| 0.2 | 1.0 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
| 0.2 | 6.7 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.2 | 1.0 | GO:0000805 | X chromosome(GO:0000805) |
| 0.2 | 0.5 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.2 | 0.7 | GO:0005940 | septin ring(GO:0005940) septin collar(GO:0032173) |
| 0.2 | 1.7 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.2 | 0.7 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.2 | 1.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 0.2 | 0.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 0.7 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.2 | 1.4 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 0.2 | 4.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.2 | 0.9 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.2 | 1.9 | GO:0043196 | varicosity(GO:0043196) |
| 0.2 | 4.4 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.2 | 2.8 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.2 | 1.1 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.2 | 3.5 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 0.4 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.2 | 0.4 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.2 | 2.4 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 3.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.2 | 5.2 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 2.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.2 | 0.6 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 0.2 | 0.6 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 0.2 | 4.8 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.2 | 0.6 | GO:0036028 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
| 0.2 | 0.4 | GO:1990462 | omegasome(GO:1990462) |
| 0.2 | 0.6 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.2 | 13.1 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.2 | 0.6 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.2 | 0.4 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.2 | 4.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.2 | 1.2 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.2 | 2.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.2 | 0.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.2 | 20.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.2 | 1.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
| 0.2 | 0.2 | GO:0042025 | viral replication complex(GO:0019034) host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 0.2 | 0.7 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.2 | 3.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.2 | 0.7 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.2 | 1.2 | GO:0097427 | microtubule bundle(GO:0097427) |
| 0.2 | 5.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.2 | 1.7 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.2 | 6.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.2 | 18.9 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.2 | 0.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.2 | 1.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.2 | 4.3 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.2 | 0.5 | GO:0071141 | SMAD protein complex(GO:0071141) |
| 0.2 | 1.0 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.2 | 5.2 | GO:0030057 | desmosome(GO:0030057) |
| 0.2 | 5.6 | GO:0099738 | cell cortex region(GO:0099738) |
| 0.2 | 0.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.2 | 1.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.2 | 2.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.2 | 0.8 | GO:0070822 | Sin3-type complex(GO:0070822) |
| 0.1 | 1.2 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
| 0.1 | 2.5 | GO:0031105 | septin complex(GO:0031105) |
| 0.1 | 0.3 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 2.4 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 0.9 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.1 | 1.6 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 0.7 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.1 | 1.8 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.1 | 2.0 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
| 0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
| 0.1 | 3.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.1 | 1.1 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.1 | 1.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.1 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 2.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 0.9 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 0.1 | 1.6 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
| 0.1 | 1.9 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.1 | 2.4 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.1 | 0.6 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.1 | 7.3 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.2 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
| 0.1 | 5.7 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.1 | 5.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 0.6 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
| 0.1 | 1.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.1 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
| 0.1 | 3.7 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.1 | 0.2 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 0.1 | 0.3 | GO:0001534 | radial spoke(GO:0001534) |
| 0.1 | 1.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 1.6 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
| 0.1 | 0.5 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 0.1 | 12.3 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.1 | 0.5 | GO:0070938 | contractile ring(GO:0070938) |
| 0.1 | 0.9 | GO:0000796 | condensin complex(GO:0000796) |
| 0.1 | 0.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 1.0 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 0.1 | 0.5 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.1 | 0.2 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.1 | 0.6 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.1 | 16.2 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.1 | 7.0 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 0.6 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.1 | 0.2 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.1 | 0.4 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.1 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 0.6 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.1 | 1.3 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 0.3 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
| 0.1 | 6.2 | GO:0031672 | A band(GO:0031672) |
| 0.1 | 4.8 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.1 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
| 0.1 | 2.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 0.7 | GO:0036157 | outer dynein arm(GO:0036157) |
| 0.1 | 0.6 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 1.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
| 0.1 | 1.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 0.4 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 0.4 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
| 0.1 | 0.4 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 0.6 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.1 | 1.9 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
| 0.1 | 0.2 | GO:0071748 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 0.1 | 0.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.1 | 8.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.1 | 0.4 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.1 | 4.6 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.1 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 27.9 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.1 | 3.3 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.1 | 0.7 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.1 | 0.1 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.1 | 0.2 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.1 | 0.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.1 | 0.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.1 | 0.2 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 0.2 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
| 0.1 | 0.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.1 | 7.2 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 0.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.1 | 1.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 1.2 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 6.9 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.1 | 0.7 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.1 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.1 | 0.6 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 9.3 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.1 | 0.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 2.1 | GO:0042641 | actomyosin(GO:0042641) |
| 0.1 | 0.3 | GO:0071547 | piP-body(GO:0071547) |
| 0.1 | 0.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 0.1 | 0.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 0.1 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.1 | 0.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.0 | 0.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.0 | 0.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.0 | 0.2 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.0 | 0.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.0 | 0.1 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.0 | 0.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.0 | 0.0 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.0 | 0.7 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.0 | 1.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.0 | 0.2 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.0 | 0.1 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.0 | 0.2 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.0 | 0.3 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.0 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.0 | 0.2 | GO:0043203 | axon hillock(GO:0043203) |
| 0.0 | 0.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.0 | 2.0 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 5.2 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.1 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.0 | 0.1 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.0 | 1.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.0 | 0.7 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.0 | 0.5 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.0 | 0.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.0 | 0.3 | GO:0000801 | central element(GO:0000801) |
| 0.0 | 2.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.0 | 0.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.0 | 3.8 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.0 | 1.0 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.0 | 0.1 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.0 | 0.1 | GO:0097362 | MCM8-MCM9 complex(GO:0097362) |
| 0.0 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.0 | 0.1 | GO:0044279 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.0 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.0 | 0.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.0 | 0.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
| 0.0 | 0.1 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.0 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.0 | 5.7 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.0 | 1.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
| 0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.0 | 0.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) ripoptosome(GO:0097342) |
| 0.0 | 0.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.0 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
| 0.0 | 0.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.0 | 0.8 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.0 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.0 | 0.4 | GO:0031932 | TORC2 complex(GO:0031932) |
| 0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.0 | 0.1 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.0 | 0.1 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.0 | 0.4 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.0 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.0 | 0.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
| 0.0 | 0.1 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.0 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 1.4 | GO:0005884 | actin filament(GO:0005884) |
| 0.0 | 0.1 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.0 | 0.1 | GO:0044450 | microtubule organizing center part(GO:0044450) |
| 0.0 | 0.0 | GO:0060198 | clathrin-sculpted vesicle(GO:0060198) |
| 0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.0 | 0.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.0 | 0.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.0 | 1.0 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.3 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.0 | 0.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.6 | 61.8 | GO:0030274 | LIM domain binding(GO:0030274) |
| 3.5 | 20.9 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 3.4 | 17.0 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
| 2.4 | 7.1 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 2.3 | 16.0 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 1.8 | 5.4 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 1.7 | 5.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.6 | 6.4 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 1.6 | 8.0 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 1.6 | 26.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 1.5 | 4.5 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 1.4 | 4.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 1.3 | 10.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
| 1.3 | 12.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 1.3 | 5.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 1.3 | 6.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 1.3 | 6.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 1.2 | 3.7 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 1.2 | 3.5 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 1.2 | 3.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 1.2 | 3.5 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 1.2 | 15.0 | GO:0070700 | BMP receptor binding(GO:0070700) |
| 1.1 | 3.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 1.1 | 3.3 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 1.1 | 6.6 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 1.1 | 8.6 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 1.0 | 10.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 1.0 | 1.0 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 0.9 | 3.7 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.9 | 22.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.9 | 0.9 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.9 | 6.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.9 | 2.7 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
| 0.9 | 7.9 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.9 | 6.1 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.9 | 5.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.8 | 3.4 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.8 | 5.1 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.8 | 2.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
| 0.8 | 2.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.8 | 2.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.8 | 5.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.8 | 2.3 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.8 | 2.3 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 0.8 | 3.1 | GO:0043426 | MRF binding(GO:0043426) |
| 0.8 | 6.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.8 | 3.8 | GO:0032810 | sterol response element binding(GO:0032810) |
| 0.7 | 5.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.7 | 4.4 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.7 | 2.2 | GO:0031783 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
| 0.7 | 12.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.7 | 3.6 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.7 | 2.1 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.7 | 2.1 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.7 | 8.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.7 | 2.1 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.7 | 2.1 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 0.7 | 20.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.7 | 3.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.7 | 1.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.7 | 13.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.7 | 7.9 | GO:0031386 | protein tag(GO:0031386) |
| 0.7 | 23.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.6 | 3.2 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
| 0.6 | 7.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.6 | 8.7 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.6 | 1.9 | GO:0032181 | heteroduplex DNA loop binding(GO:0000404) double-strand/single-strand DNA junction binding(GO:0000406) dinucleotide repeat insertion binding(GO:0032181) |
| 0.6 | 5.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.6 | 4.3 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.6 | 1.8 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.6 | 10.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.6 | 1.8 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
| 0.6 | 1.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.6 | 3.6 | GO:0052841 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.6 | 2.9 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.6 | 1.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.6 | 3.4 | GO:0097001 | ceramide binding(GO:0097001) |
| 0.6 | 1.7 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.6 | 3.4 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.6 | 4.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.6 | 6.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.5 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.5 | 2.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.5 | 1.6 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.5 | 3.2 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.5 | 4.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.5 | 3.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.5 | 3.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
| 0.5 | 3.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.5 | 3.0 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.5 | 2.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.5 | 4.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.5 | 1.4 | GO:0050405 | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity(GO:0047322) [acetyl-CoA carboxylase] kinase activity(GO:0050405) |
| 0.5 | 4.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.5 | 1.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.5 | 1.9 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.5 | 1.4 | GO:0036033 | mediator complex binding(GO:0036033) |
| 0.5 | 2.3 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.5 | 1.4 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.5 | 4.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.5 | 5.0 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.5 | 1.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.4 | 1.3 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
| 0.4 | 5.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.4 | 1.3 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.4 | 3.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.4 | 6.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.4 | 10.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.4 | 1.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.4 | 0.8 | GO:0038064 | collagen receptor activity(GO:0038064) |
| 0.4 | 4.2 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.4 | 1.7 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.4 | 2.9 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.4 | 4.2 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.4 | 1.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.4 | 6.1 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
| 0.4 | 2.0 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.4 | 1.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
| 0.4 | 1.2 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 0.4 | 1.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 0.4 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
| 0.4 | 3.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.4 | 7.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.4 | 1.1 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.4 | 1.9 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.4 | 1.1 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
| 0.4 | 1.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.4 | 1.5 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.4 | 1.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.4 | 1.1 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
| 0.4 | 3.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.4 | 1.1 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.4 | 5.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.4 | 1.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.4 | 2.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.4 | 1.1 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.4 | 2.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.3 | 1.0 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.3 | 1.4 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.3 | 1.3 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
| 0.3 | 4.0 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.3 | 6.3 | GO:0031432 | titin binding(GO:0031432) |
| 0.3 | 1.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.3 | 1.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.3 | 1.6 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.3 | 2.9 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.3 | 1.6 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.3 | 4.2 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.3 | 2.6 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.3 | 5.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.3 | 0.9 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.3 | 0.9 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.3 | 0.9 | GO:0070696 | transmembrane receptor protein serine/threonine kinase binding(GO:0070696) |
| 0.3 | 3.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.3 | 1.5 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.3 | 1.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.3 | 1.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.3 | 4.8 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.3 | 1.5 | GO:0097617 | RNA strand annealing activity(GO:0033592) annealing activity(GO:0097617) |
| 0.3 | 0.9 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.3 | 2.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.3 | 1.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.3 | 9.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.3 | 2.0 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.3 | 2.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.3 | 1.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.3 | 3.6 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.3 | 2.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.3 | 2.4 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.3 | 1.1 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.3 | 2.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.3 | 1.3 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.3 | 1.8 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.3 | 1.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.3 | 1.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.3 | 3.1 | GO:0048185 | activin binding(GO:0048185) |
| 0.3 | 3.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.3 | 1.0 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.3 | 0.3 | GO:0001221 | transcription cofactor binding(GO:0001221) |
| 0.3 | 2.0 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
| 0.3 | 6.4 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.3 | 2.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.3 | 6.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.3 | 0.8 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.2 | 0.7 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.2 | 0.7 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.2 | 1.9 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
| 0.2 | 1.4 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.2 | 6.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.2 | 8.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
| 0.2 | 3.6 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.2 | 1.2 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.2 | 1.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.2 | 0.7 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
| 0.2 | 12.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.2 | 8.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.2 | 1.2 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.2 | 6.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.2 | 1.8 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.2 | 3.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.2 | 0.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.2 | 1.4 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.2 | 0.7 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.2 | 5.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.2 | 1.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.2 | 0.2 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.2 | 2.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.2 | 1.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.2 | 0.7 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.2 | 12.4 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.2 | 0.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.2 | 1.1 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.2 | 1.7 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 0.2 | 2.6 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.2 | 6.7 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.2 | 3.2 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.2 | 0.6 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
| 0.2 | 1.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.2 | 3.9 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) |
| 0.2 | 3.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.2 | 2.3 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.2 | 0.8 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.2 | 1.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.2 | 0.8 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.2 | 1.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.2 | 0.6 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.2 | 3.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.2 | 1.4 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.2 | 0.6 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 0.2 | 1.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.2 | 6.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.2 | 2.2 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.2 | 0.8 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
| 0.2 | 0.8 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.2 | 0.6 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.2 | 9.1 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.2 | 0.6 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.2 | 1.0 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.2 | 3.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.2 | 1.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.2 | 1.7 | GO:0045159 | myosin II binding(GO:0045159) |
| 0.2 | 0.6 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.2 | 0.6 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.2 | 0.9 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
| 0.2 | 7.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.2 | 0.7 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.2 | 0.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.2 | 2.0 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.2 | 0.9 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.2 | 1.3 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.2 | 2.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.2 | 0.7 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.2 | 0.7 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.2 | 1.0 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.2 | 0.2 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.2 | 0.5 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 1.9 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.2 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.2 | 0.8 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
| 0.2 | 1.5 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.2 | 0.8 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.2 | 1.5 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.2 | 2.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.2 | 14.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.2 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 0.7 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.2 | 0.8 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
| 0.2 | 1.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.2 | 0.5 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.2 | 1.5 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.2 | 10.2 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.2 | 1.0 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.2 | 0.5 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.2 | 0.5 | GO:0008940 | nitrate reductase activity(GO:0008940) |
| 0.2 | 0.3 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.2 | 3.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.2 | 0.5 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.2 | 1.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.2 | 5.1 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
| 0.2 | 0.6 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.2 | 4.0 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.2 | 0.9 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.2 | 1.5 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.2 | 0.3 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.2 | 1.1 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.2 | 0.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.1 | 0.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 0.1 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.1 | 1.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.1 | 0.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.1 | 4.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.1 | 0.9 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.1 | 0.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.1 | 1.0 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.1 | 0.4 | GO:0030626 | U12 snRNA binding(GO:0030626) |
| 0.1 | 1.3 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.1 | 1.0 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.1 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 2.0 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.1 | 0.6 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.1 | 2.8 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.1 | 0.7 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.1 | 0.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 2.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.1 | 1.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.1 | 5.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 10.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 0.5 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.1 | 1.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 1.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.1 | 0.5 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.1 | 0.4 | GO:0052825 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
| 0.1 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.1 | 0.5 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 0.1 | 0.5 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.1 | 2.3 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.1 | 0.4 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.1 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 4.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.1 | 2.4 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 4.3 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.1 | 0.8 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.1 | 0.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 0.6 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 1.8 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.1 | 78.2 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.1 | 0.4 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
| 0.1 | 0.4 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.1 | 0.8 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.9 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.1 | 0.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.1 | 0.4 | GO:0019961 | interferon binding(GO:0019961) |
| 0.1 | 1.0 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.1 | 0.7 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.1 | 0.4 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.1 | 1.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 2.6 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.1 | 0.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 0.6 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
| 0.1 | 3.0 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 0.5 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.1 | 5.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 1.0 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.1 | 27.6 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 0.1 | 0.6 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 0.1 | 36.0 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.1 | 1.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.1 | 0.4 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 0.1 | 1.2 | GO:0034979 | NAD-dependent protein deacetylase activity(GO:0034979) |
| 0.1 | 0.6 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 2.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.1 | 0.4 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.1 | 1.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 0.4 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.1 | 1.3 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 1.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.1 | 0.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.1 | 0.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 0.1 | GO:0047115 | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity(GO:0047115) |
| 0.1 | 0.3 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.1 | 5.0 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.1 | 0.4 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.1 | 0.5 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 4.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 2.3 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 1.7 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
| 0.1 | 0.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 4.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.1 | 0.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.1 | 0.3 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.1 | 0.7 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.1 | 0.8 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.1 | 0.4 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.1 | 0.2 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
| 0.1 | 0.4 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
| 0.1 | 0.8 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.1 | 0.4 | GO:0051800 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity(GO:0051800) |
| 0.1 | 3.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.1 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
| 0.1 | 0.6 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.1 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.1 | 0.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.1 | 0.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.1 | 0.6 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 5.1 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.1 | 0.4 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
| 0.1 | 0.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.1 | 1.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 1.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.1 | 1.0 | GO:0004954 | prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
| 0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.1 | 0.8 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
| 0.1 | 0.8 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.1 | 1.4 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 0.2 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.1 | 0.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.1 | 4.7 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.1 | 1.0 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.1 | 0.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 1.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 3.0 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
| 0.1 | 0.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 0.2 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.1 | 0.9 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 0.9 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.1 | 0.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.1 | 5.6 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
| 0.1 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.1 | 0.2 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
| 0.1 | 0.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.1 | 7.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
| 0.1 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.1 | 0.3 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.1 | 0.2 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 0.1 | 0.5 | GO:0032183 | SUMO binding(GO:0032183) |
| 0.1 | 1.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 2.9 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 1.1 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.1 | 1.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 0.1 | 1.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.1 | 0.8 | GO:0019841 | retinol binding(GO:0019841) |
| 0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.1 | 0.6 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.1 | 1.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.1 | 0.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 0.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.1 | 0.4 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 0.6 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.1 | 1.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.1 | 0.9 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.1 | 0.4 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
| 0.1 | 0.3 | GO:1902444 | riboflavin binding(GO:1902444) |
| 0.1 | 2.1 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 1.8 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.1 | 0.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.1 | 0.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.1 | 0.2 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
| 0.1 | 0.2 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.1 | 0.2 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.1 | 0.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.1 | 0.3 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.1 | 2.4 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.1 | 0.4 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
| 0.1 | 0.2 | GO:0033867 | Fas-activated serine/threonine kinase activity(GO:0033867) |
| 0.1 | 0.5 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.1 | 1.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 1.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.1 | 0.4 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 0.4 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.1 | 0.3 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
| 0.1 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.1 | 0.8 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.1 | 0.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.1 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.1 | 0.2 | GO:0003983 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.1 | 1.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.1 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.1 | 0.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.1 | 0.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.1 | 1.2 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 0.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 0.5 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.1 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
| 0.1 | 0.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.1 | 0.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.1 | 11.1 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.8 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.1 | 3.8 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
| 0.1 | 0.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.1 | 0.3 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.1 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.0 | 0.1 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
| 0.0 | 0.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.0 | 1.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.0 | 0.6 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.0 | 2.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 0.3 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
| 0.0 | 0.3 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
| 0.0 | 0.0 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
| 0.0 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 0.0 | 0.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 0.0 | 0.9 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.0 | 1.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.0 | 0.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.0 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.0 | 0.1 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
| 0.0 | 0.1 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
| 0.0 | 0.1 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.0 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.0 | 0.2 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.0 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 0.2 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 0.0 | 0.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.0 | 0.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.0 | 0.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.0 | 0.3 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
| 0.0 | 0.6 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.0 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.0 | 0.1 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
| 0.0 | 0.3 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.0 | 0.1 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.0 | 1.4 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.0 | 0.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.0 | 1.2 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.0 | 0.1 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
| 0.0 | 0.1 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
| 0.0 | 0.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.0 | 0.6 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.0 | 0.5 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.0 | 0.2 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.0 | 0.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 0.0 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.0 | 0.5 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.0 | 0.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
| 0.0 | 0.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 0.0 | 0.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.0 | 0.1 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.0 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
| 0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.0 | 0.2 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.0 | 2.1 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.0 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
| 0.0 | 0.1 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 0.0 | 0.1 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.0 | 0.9 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
| 0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.0 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.0 | 0.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.0 | 0.3 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.0 | 0.3 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.0 | 0.3 | GO:0016595 | glutamate binding(GO:0016595) |
| 0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.0 | 0.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.0 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 0.3 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
| 0.0 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
| 0.0 | 1.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
| 0.0 | 1.5 | GO:0004497 | monooxygenase activity(GO:0004497) |
| 0.0 | 0.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.0 | 0.3 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.0 | 0.1 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.0 | 0.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.0 | 0.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.0 | 0.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.0 | 3.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
| 0.0 | 0.1 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.0 | 1.3 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 0.1 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
| 0.0 | 0.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.0 | 0.2 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.0 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.0 | 0.2 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.0 | 0.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.0 | 0.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.0 | 0.5 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
| 0.0 | 2.6 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
| 0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.0 | 0.1 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.0 | 0.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.0 | 0.2 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
| 0.0 | 0.0 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.0 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.0 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.0 | 0.1 | GO:0023025 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
| 0.0 | 0.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.0 | 0.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 0.0 | 0.1 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.0 | 0.4 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.0 | 0.6 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.0 | 0.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.0 | 0.0 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.0 | 0.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 84.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.6 | 34.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.5 | 8.8 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.5 | 30.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.4 | 11.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.4 | 28.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.3 | 17.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.3 | 13.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.3 | 13.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.3 | 19.3 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.3 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.3 | 14.7 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.3 | 13.3 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.3 | 10.5 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.3 | 1.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.3 | 1.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.3 | 13.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.3 | 6.4 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.3 | 7.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.3 | 3.8 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.3 | 5.7 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 0.3 | 8.6 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 1.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.3 | 4.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.2 | 2.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.2 | 0.7 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.2 | 11.7 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.2 | 26.9 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 13.1 | PID BMP PATHWAY | BMP receptor signaling |
| 0.2 | 0.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.2 | 5.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.2 | 14.9 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.2 | 6.9 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.2 | 5.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.2 | 0.7 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.2 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.2 | 1.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.2 | 2.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 0.3 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.1 | 14.2 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 12.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 4.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 2.8 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 0.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 6.3 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.1 | 0.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 3.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.1 | 1.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.1 | 5.8 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 7.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.1 | 5.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 3.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.1 | 2.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
| 0.1 | 0.8 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 1.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.1 | 8.6 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 0.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 0.1 | 0.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 5.1 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 3.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.1 | 2.1 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
| 0.1 | 3.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 4.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 2.5 | PID ATM PATHWAY | ATM pathway |
| 0.1 | 1.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
| 0.1 | 2.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.1 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.1 | 1.7 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 1.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.0 | 1.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.0 | 1.4 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 0.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.0 | 0.2 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.0 | 0.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.0 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.0 | 0.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.0 | 0.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 1.4 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.0 | 0.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.0 | 0.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.0 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.0 | 0.1 | PID EPO PATHWAY | EPO signaling pathway |
| 0.0 | 0.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.0 | 0.1 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 4.4 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.8 | 1.7 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
| 0.8 | 26.8 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.7 | 3.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.7 | 10.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.6 | 29.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.6 | 8.4 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
| 0.5 | 8.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.5 | 21.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.5 | 7.8 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
| 0.5 | 7.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.4 | 15.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.4 | 8.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
| 0.4 | 6.8 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.4 | 20.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.4 | 0.7 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.4 | 2.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.3 | 8.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.3 | 5.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.3 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.3 | 6.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.3 | 8.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.3 | 5.1 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
| 0.3 | 8.6 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.3 | 1.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.3 | 21.0 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.3 | 4.1 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.3 | 10.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.3 | 1.3 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
| 0.3 | 13.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.3 | 7.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.3 | 2.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.2 | 2.5 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.2 | 3.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.2 | 11.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.2 | 1.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.2 | 5.2 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 16.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.2 | 20.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 5.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.2 | 0.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.2 | 8.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.2 | 3.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 0.2 | 8.2 | REACTOME KINESINS | Genes involved in Kinesins |
| 0.2 | 5.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.2 | 6.7 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.2 | 2.0 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 16.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.2 | 0.8 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.2 | 3.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.2 | 3.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.2 | 4.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.2 | 5.8 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.2 | 6.3 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.2 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.2 | 0.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.2 | 16.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.2 | 3.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.2 | 3.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.2 | 1.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
| 0.2 | 1.4 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.2 | 4.9 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.2 | 1.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.2 | 0.9 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 0.2 | 3.6 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 5.4 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.1 | 4.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 1.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.1 | 4.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.1 | 0.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 5.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 3.2 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.1 | 0.5 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.1 | 3.2 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.1 | 3.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 9.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 3.8 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.1 | 0.8 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.1 | 2.2 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
| 0.1 | 2.6 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
| 0.1 | 2.3 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.1 | 4.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.1 | 10.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.1 | 0.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 3.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 1.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.1 | 2.8 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.1 | 0.2 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 0.1 | 0.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.1 | 0.9 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 3.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 1.0 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
| 0.1 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.1 | 1.7 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.1 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.1 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.1 | 4.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.1 | 1.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 0.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.1 | 1.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 0.1 | 1.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 3.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 3.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.1 | 1.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.1 | 0.8 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 1.1 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.1 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 1.4 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 3.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 2.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.1 | 0.5 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
| 0.0 | 0.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 0.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.0 | 0.6 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 0.0 | 3.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 1.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.0 | 1.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.0 | 0.3 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.0 | 0.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 0.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.0 | 0.9 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.0 | 1.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.0 | 0.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.0 | 1.0 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.0 | 0.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.0 | 0.8 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.0 | 1.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.0 | 1.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.0 | 4.1 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 2.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
| 0.0 | 1.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.0 | 0.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.0 | 0.1 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.0 | 0.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.0 | 0.1 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.0 | 0.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.0 | 0.3 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.0 | 0.3 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
| 0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.0 | 0.4 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.0 | 0.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.0 | 0.5 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |